Trials / Completed
CompletedNCT05530915
Guayusa: The Effect of an Herbal Extract on Alertness and Mental Fatigue
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- PepsiCo Global R&D · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this randomized, double-blind, placebo-controlled, cross-over study is to assess the acute effects of a novel ingredient, guayusa on alertness and mental fatigue compared to a placebo. This trial will utilize the COMPASS cognitive task and cognitive demand battery (CDB) and mood, motivation, and energy measures with assessments taking place at baseline, 60- and 120-minutes post treatment on three separate testing days separated by \~7 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Gel capsule | Single capsule per dose |
Timeline
- Start date
- 2022-07-27
- Primary completion
- 2022-11-07
- Completion
- 2022-11-07
- First posted
- 2022-09-07
- Last updated
- 2022-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05530915. Inclusion in this directory is not an endorsement.